By Paul M. Selzer(eds.)
Content material:
Chapter 1 Visceral Leishmaniasis – present remedies and desires (pages 1–15): Poonam Salotra, Ruchi Singh and Karin Seifert
Chapter 2 Chemotherapy of Leishmaniasis: A Veterinary point of view (pages 17–35): Maria Jesus Corral?Caridad and Jose Maria Alunda
Chapter three Pharmacological Metabolomics in Trypanosomes (pages 37–56): Darren J. Creek, Isabel M. Vincent and Michael P. Barrett
Chapter four Drug layout and Screening through In Silico ways (pages 57–79): Mattia Mori and Maurizio Botta
Chapter five Computational methods and Collaborative Drug Discovery for Trypanosomal illnesses (pages 81–102): Sean Ekins and Barry A. Bunin
Chapter 6 interplay of Leishmania Parasites with Host Cells and its useful effects (pages 103–119): Uta Schurigt, Anita Masic and Heidrun Moll
Chapter 7 functionality of Glycosomes within the Metabolism of Trypanosomatid Parasites and the Promise of Glycosomal Proteins as Drug ambitions (pages 121–151): Melisa Gualdron?Lopez, Paul A. M. Michels, Wilfredo Quinones, Ana J. Caceres, Luisana Avilan and Juan?Luis Concepcion
Chapter eight Glyoxalase Enzymes in Trypanosomatids (pages 153–166): Marta Sousa Silva, Antonio E. N. Ferreira, Ricardo Gomes, Ana M. Tomas, Ana Ponces Freire and Carlos Cordeiro
Chapter nine Trypanothione?Based Redox Metabolism of Trypanosomatids (pages 167–199): Marcelo A. Comini and Prof. Dr.med. Dr.h.c. Leopold Flohe
Chapter 10 Thiol Peroxidases of Trypanosomatids (pages 201–213): Helena Castro and Ana M. Tomas
Chapter eleven Peroxynitrite as a Cytotoxic Effector opposed to Trypanosoma Cruzi: Oxidative Killing and Antioxidant Resistance Mechanisms (pages 215–236): Madia Trujillo, Maria Noel Alvarez, Lucia Piacenza, Martin Hugo, Gonzalo Peluffo and Rafael Radi
Chapter 12 Selenoproteome of Kinetoplastids (pages 237–242): Alexei V. Lobanov and Vadim N. Gladyshev
Chapter thirteen Replication equipment of Kinetoplast DNA (pages 243–260): Rachel Bezalel?Buch, Nurit Yaffe and Joseph Shlomai
Chapter 14 lifestyles and demise of Trypanosoma Brucei: New views for Drug improvement (pages 261–277): Torsten Barth, Jasmin Stein, Stefan Mogk, Caroline Schonfeld, Bruno ok. Kubata and Michael Duszenko
Chapter 15 Rational choice of Anti?Microbial Drug ambitions: exact or Conserved? (pages 279–296): Boris Rodenko and Harry P. de Koning
Chapter sixteen Drug pursuits in Trypanosomal and Leishmanial Pentose Phosphate Pathway (pages 297–313): Marcelo A. Comini, Cecilia Ortiz and Juan Jose Cazzulo
Chapter 17 GDP?Mannose: A Key element for goal id and Drug layout in Kinetoplastids (pages 315–334): Sebastien Pomel and Philippe M. Loiseau
Chapter 18 Transporters in Anti?Parasitic Drug improvement and Resistance (pages 335–349): Vincent Delespaux and Harry P. de Koning
Chapter 19 Peptidases in Autophagy are healing pursuits for Leishmaniasis (pages 351–364): Roderick A. M. Williams
Chapter 20 Proteases of Trypanosoma brucei (pages 365–382): Dietmar Steverding
Chapter 21 Screening techniques in the direction of Trypanothione Reductase (pages 383–404): Mathias Beig, Frank Oellien, R. Luise Krauth?Siegel and Prof. Dr. Paul M. Selzer
Chapter 22 Redox?Active brokers in Reactions related to the Trypanothione/Trypanothione Reductase?based procedure to struggle Kinetoplastidal Parasites (pages 405–428): Thibault Gendron, Don Antoine Lanfranchi and Elisabeth Davioud?Charvet
Chapter 23 Inhibition of Trypanothione Synthetase as a healing inspiration (pages 429–443): Dr. Oliver Koch, Dr. Timo Jager, Prof. Dr.med. Dr.h.c. Leopold Flohe and Prof. Dr. Paul M. Selzer
Chapter 24 concentrating on the Trypanosomatidic Enzymes Pteridine Reductase and Dihydrofolate Reductase (pages 445–472): Stefania Ferrari, Valeria Losasso, Puneet Saxena and Maria Paola Costi
Chapter 25 Contribution to New cures for Chagas affliction (pages 473–487): Patricia S. Doyle and Juan C. Engel
Chapter 26 Ergosterol Biosynthesis for the categorical remedy of Chagas ailment: From easy technological know-how to medical Trials (pages 489–514): Julio A. Urbina
Chapter 27 New advancements within the therapy of Late?Stage Human African Trypanosomiasis (pages 515–529): Cyrus J. Bacchi, Robert T. Jacobs and Nigel Yarlett
Read or Download Trypanosomatid Diseases: Molecular Routes to Drug Discovery PDF
Similar diseases books
Production diseases in farm animals: 12th international conference
Excessive generating cattle are completely challenged by means of numerous elements: loss of right foodstuff (deficit/surplus), housing structures, infections and pressure. The prevalence, direction and consequence of construction illnesses are altering consistently. for that reason, new details on prevention, analysis and remedy of construction illnesses is required.
The Washington Manual Internship Survival Guide, 4th Edition
This 4th version of The Washington guide Internship Survival advisor includes the entire crucial details wanted for a profitable internship. Designed to assist citizens enhance their abilities from their first actual day at the wards, this pocket-size reference e-book deals functional clinical recommendation for the head 10 workups and customary calls and court cases citizens will stumble upon in the course of their rotations, together with key historical past, what to not omit, and while to name for aid.
Neglected Tropical Diseases - Middle East and North Africa
The center East and North Africa (MENA) is very endemic for a number of ignored tropical ailments (NTDs), together with viral, bacterial, protozoan and helminth infections. This new quantity covers the main favourite NTDs present in approximately 22 MENA international locations emphasizing the affliction burden, scientific manifestations and keep watch over methods.
2015 BMA clinical publication Awards 1st Prize Award Winner in easy and medical Sciences type! An built-in method of instructing simple sciences and medical drugs has intended that clinical scholars were pushed to a number easy technology textbooks to discover suitable info. clinical Sciences is designed to do the combination for you.
Additional info for Trypanosomatid Diseases: Molecular Routes to Drug Discovery
Sample text
2008) New treatment approach in indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine. Clin. Infect. H. (2006) Drug resistance in leishmaniasis. Clin. Microbiol. , 19, 111–126. Seifert, K. (2011) Structures, targets and recent approaches in anti-leishmanial drug discovery and development. Open Med. Chem. , 5, 31–39. Ghalib, H. and Modabber, F. (2007) Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis.
The parasites are mainly present in the superficial epidermis, and easily detected in nodular lesion compared to macular and papular lesions [59]. Neuritis in small cutaneous nerves indicating peripheral nerve involvement, mucosal lesions with destructive complication in oronasal regions, and ocular lesions have been described in Sudanese PKDL, but appear rare in Indian PKDL with a sole report of neuritis [54,57,60]. Immunosuppression, reactivation of residual parasite, or reinfection in a viscerally immune person is thought to be the underlying mechanism in the development of PKDL [54,58,61].
H. (2011) A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit. PLoS Negl. Trop. , 5, e1253. j15 j17 2 Chemotherapy of Leishmaniasis: A Veterinary Perspective María Jes us Corral-Caridad and Jose María Alundaà Abstract Leishmania species cause a variety of in part fatal diseases in man and animals, the prominent veterinary manifestation being canine leishmaniasis caused by L. infantum (syn. L. chagasi), which also causes visceral leishmaniasis in humans.